Drug Profile
RO 317467
Latest Information Update: 09 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class Antirheumatics
- Mechanism of Action Collagenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Osteoarthritis; Rheumatoid arthritis
Most Recent Events
- 09 Nov 2006 Discontinued - Preclinical for Osteoarthritis (unspecified route)
- 09 Nov 2006 Discontinued - Preclinical for Rheumatoid arthritis (unspecified route)